Daniel R. Quast
About
Daniel R. Quast is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Pulmonary and Respiratory Medicine.
According to data from OpenAlex, Daniel R. Quast has authored 31 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 13 papers in Surgery and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Daniel R. Quast's work include Diabetes Treatment and Management (11 papers), Diabetes Management and Research (6 papers) and Pharmacology and Obesity Treatment (4 papers). Daniel R. Quast is often cited by papers focused on Diabetes Treatment and Management (11 papers), Diabetes Management and Research (6 papers) and Pharmacology and Obesity Treatment (4 papers). Daniel R. Quast collaborates with scholars based in Germany, Australia and Switzerland. Daniel R. Quast's co-authors include Michael A. Nauck, Jakob Wefers, Juris J. Meier, Andreas Pfeiffer, Christoph Kapitza, Björn A. Menge, R. Schneider, Gabriela Möslein, Alexander Brunner and Reto Babst and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Diabetes.
In The Last Decade
Daniel R. Quast
27 papers receiving 1.6k citations
Hit Papers
Peers
Daniel R. Quast
Stanley S. Schwartz United States
Stephanie M. Gustavson United States
Katelyn Brown United States
Bernt Johan von Scholten Denmark
Dae Sung Kim South Korea
Narihito Yoshioka Japan
Thomas Blevins United States
Uta Schwanebeck Germany
Matthew P. Gilbert United States
Carolina Solis‐Herrera United States
Citations per year, relative to Daniel R. Quast Daniel R. Quast (= 1×)
peers
Stanley S. Schwartz
Countries citing papers authored by Daniel R. Quast
Since
Specialization
Citations
This map shows the geographic impact of Daniel R. Quast's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel R. Quast with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel R. Quast more than expected).
Fields of papers citing papers by Daniel R. Quast
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Daniel R. Quast. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel R. Quast. The network helps show where Daniel R. Quast may publish in the future.
Co-authorship network of co-authors of Daniel R. Quast
This figure shows the co-authorship network connecting the top 25 collaborators of Daniel R. Quast. A scholar is included among the top collaborators of Daniel R. Quast based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel R. Quast. Daniel R. Quast is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Quast, Daniel R., Michelle J. Bound, Karen L. Jones, et al.. (2025). Effects of Metformin on Postprandial Blood Pressure, Heart Rate, Gastric Emptying, GLP-1, and Prevalence of Postprandial Hypotension in Type 2 Diabetes: A Double-Blind Placebo-Controlled Crossover Study. Diabetes. 74(4). 611–618.
2.
Nagl, Sandra, Anna Muzalyova, Christoph Römmele, et al.. (2025). Underwater vs. Conventional Endoscopic Submucosal Dissection: Retrospective Analysis from a German High-Volume Center. Zeitschrift für Gastroenterologie. 63(8). 844–850.
3.
Prehn, Christian, et al.. (2025). Neurological post-COVID syndrome is associated with substantial impairment of verbal short-term and working memory. Scientific Reports. 15(1). 1695–1695.
4.
Quast, Daniel R., Cong Xie, Michelle J. Bound, et al.. (2024). Randomised comparison of intravenous and subcutaneous routes of glucagon‐like peptide‐1 administration for lowering plasma glucose in hyperglycaemic subjects with type 2 diabetes. Diabetes Obesity and Metabolism. 26(9). 3897–3905.
5.
Jalleh, Ryan J., Mark P. Plummer, Chinmay S. Marathe, et al.. (2024). Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirzepatide. The Journal of Clinical Endocrinology & Metabolism. 110(1). 1–15.
6.
Jalleh, Ryan J., Chinmay S. Marathe, Christopher Rayner, et al.. (2024). Physiology and Pharmacology of Effects of GLP-1-based Therapies on Gastric, Biliary and Intestinal Motility. Endocrinology. 166(1).
7.
Rached, Nessr Abu, Thilo Gambichler, Johannes W. Dietrich, et al.. (2023). Screening for Diabetes Mellitus in Patients with Hidradenitis Suppurativa—A Monocentric Study in Germany. International Journal of Molecular Sciences. 24(7). 6596–6596.
8.
Rached, Nessr Abu, Johannes W. Dietrich, Daniel R. Quast, et al.. (2023). Primary Thyroid Dysfunction Is Prevalent in Hidradenitis Suppurativa and Marked by a Signature of Hypothyroid Graves’ Disease: A Case–Control Study. Journal of Clinical Medicine. 12(23). 7490–7490.
9.
Nauck, Michael A., et al.. (2023). Meta‐analysis of head‐to‐head clinical trials comparing incretin‐based glucose‐lowering medications and basal insulin: An update including recently developed glucagon‐like peptide‐1 ( GLP ‐1) receptor agonists and the glucose‐dependent insulinotropic polypeptide/ GLP ‐1 receptor co‐agonist tirzepatide. Diabetes Obesity and Metabolism. 25(5). 1361–1371.
10.
Quast, Daniel R., et al.. (2023). Longitudinal data on humoral response and neutralizing antibodies against SARS-CoV-2 Omicron BA.1 and subvariants BA.4/5 and BQ.1.1 after COVID-19 vaccination in cancer patients. Journal of Cancer Research and Clinical Oncology. 149(12). 10633–10644.
11.
Quast, Daniel R., et al.. (2023). Rate of atrial fibrillation and flutter induced tachycardiomyopathy in a cohort of hospitalized patients with heart failure and detection of indicators for improved diagnosis. Frontiers in Cardiovascular Medicine. 9. 940060–940060.
12.
Meister, Toni Luise, Yannick Brüggemann, Natalie Heinen, et al.. (2022). Low Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Transmission by Fomites: A Clinical Observational Study in Highly Infectious Coronavirus Disease 2019 Patients. The Journal of Infectious Diseases. 226(9). 1608–1615.
13.
Gambichler, Thilo, Thomas Mentzel, Ingo Stricker, et al.. (2022). Undifferentiated pleomorphic sarcoma of the breast with neoplastic fever: case report and genomic characterization. Journal of Cancer Research and Clinical Oncology. 149(4). 1465–1471.
14.
Quast, Daniel R., et al.. (2022). Attitude towards and perception of individual safety after SARS-CoV-2 vaccination among German cancer patients. Journal of Cancer Research and Clinical Oncology. 149(5). 1985–1992.
15.
Nauck, Michael A. & Daniel R. Quast. (2021). Cardiovascular Safety and Benefits of Semaglutide in Patients With Type 2 Diabetes: Findings From SUSTAIN 6 and PIONEER 6. Frontiers in Endocrinology. 12. 645566–645566.
16.
Nauck, Michael A., Daniel R. Quast, Jakob Wefers, & Juris J. Meier. (2020). GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art. Molecular Metabolism. 46. 101102–101102.
17.
Quast, Daniel R., et al.. (2020). Successful Treatment of Severe Digitoxin Intoxication with CytoSorb® Hemoadsorption. Blood Purification. 50(1). 137–140.
18.
Becker, Björn, et al.. (2020). Day-to-Day Variations in Fasting Plasma Glucose Do Not Influence Gastric Emptying in Subjects With Type 1 Diabetes. Diabetes Care. 44(2). 479–488.
19.
Quast, Daniel R., et al.. (2015). Long-term outcome of sporadic and FAP-associated desmoid tumors treated with high-dose selective estrogen receptor modulators and sulindac: a single-center long-term observational study in 134 patients. Familial Cancer. 15(1). 31–40.
20.
Baumgartner, Ralf W., et al.. (2015). Is the cortical thickness index a valid parameter to assess bone mineral density in geriatric patients with hip fractures?. Archives of Orthopaedic and Trauma Surgery. 135(6). 805–810.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Stanley S. Schwartz Breakdown of academic impact, for papers by Stephanie M. Gustavson Breakdown of academic impact, for papers by Katelyn Brown Breakdown of academic impact, for papers by Bernt Johan von Scholten Breakdown of academic impact, for papers by Dae Sung Kim Breakdown of academic impact, for papers by Narihito Yoshioka Breakdown of academic impact, for papers by Thomas Blevins Breakdown of academic impact, for papers by Uta Schwanebeck Breakdown of academic impact, for papers by Matthew P. Gilbert Breakdown of academic impact, for papers by Carolina Solis‐Herrera